Skip to main content

Stock Yards Bancorp Reports First Quarter Earnings of $36.6 Million or $1.24 Per Diluted Share

Results Highlighted by Strong Loan Growth and Excellent Credit Quality LOUISVILLE, Ky., April 22, 2026 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today reported earnings of $36.6 million, or $1.24 per diluted share, for the first quarter ended March 31, 2026. This compares to net income of $33.3 million, or $1.13 per diluted share, for the first quarter ended March 31, 2025. Solid loan growth across all markets, combined with net interest margin expansion, strong credit quality metrics and record net new business generation from the Wealth Management & Trust (WM&T) group, contributed to first quarter...

Continue reading

RenX Enterprises Expects First Quarter 2026 Revenue of More Than $3.5 Million

Revenue expected to reflect sequential growth over the fourth quarter of 2025 MIAMI, FL, April 22, 2026 (GLOBE NEWSWIRE) — RenX Enterprises Corp. “RenX” (NASDAQ: RENX), a biomass recycling, logistics, and real estate company, today announced a business update and expected revenue for the quarter ended March 31, 2026. Preliminary Unaudited First Quarter 2026 Revenue On a consolidated basis, the Company expects to report revenue in excess of $3.5 million for the first quarter of 2026, reflecting sequential growth over the fourth quarter of 2025. The expected growth reflects anticipated stronger material sales at the Company’s Myakka City organics processing facility and an expected meaningful step-up in logistics revenue across the Company’s transportation operations. First quarter material sales at Myakka City, are expected to include...

Continue reading

Old National Bancorp Reports First Quarter 2026 Results

EVANSVILLE, Ind., April 22, 2026 (GLOBE NEWSWIRE) —Old National Bancorp (NASDAQ: ONB) reports 1Q26 net income applicable to common shares of $229.6 million, diluted EPS of $0.59; $237.7 million and $0.61 on an adjusted1 basis, respectively.CEO COMMENTARY:“Old National’s first-quarter results reflect disciplined execution and a strong start to the year,” said Chairman and CEO Jim Ryan. “We delivered strong loan growth, controlled expenses, and maintained strong credit, capital, and liquidity levels, while also taking decisive action on capital returns. Momentum across our businesses continues to build, and nothing we’re seeing changes our confidence in our full-year expectations.”FIRST QUARTER HIGHLIGHTS2:Net IncomeNet income applicable to common shares of $229.6 million; adjusted...

Continue reading

Fidelity D & D Bancorp, Inc. Reports First Quarter 2026 Financial Results

DUNMORE, Pa., April 22, 2026 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking subsidiary, The Fidelity Deposit and Discount Bank, announced its unaudited, consolidated financial results for the three-month period ended March 31, 2026. Unaudited Financial Information Net income for the quarter ended March 31, 2026 was $7.5 million, or $1.28 per diluted share, compared to $6.0 million, or $1.03 per diluted share, for the quarter ended March 31, 2025.  The $1.5 million, or 25%, increase in net income resulted primarily from a $2.4 million increase in net interest income coupled with a $0.2 million increase in non-interest income. This was partially offset by a $0.6 million increase in non-interest expense and a $0.6 million increase in the provision for credit losses on the growth of loans and unfunded...

Continue reading

Stifel Reports First Quarter 2026 Results

ST. LOUIS, April 22, 2026 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.48 billion for the three months ended March 31, 2026, compared with $1.26 billion a year ago. Net income available to common shareholders was $242.1 million, or $1.48 per diluted common share, compared with $43.7 million, or $0.26 per diluted common share (1) for the first quarter of 2025. Non-GAAP net income available to common shareholders was $237.5 million, or $1.45 per diluted common share for the first quarter of 2026. Ronald J. Kruszewski, Chairman and Chief Executive Officer, said “Stifel delivered record first quarter results with approximately $1.5 billion in revenue and earnings per share of $1.48. Even amid heightened volatility driven by geopolitical events, we achieved our strongest ever first quarter performance...

Continue reading

Rogers Communications Reports First Quarter 2026 Results

Rogers reports continued year-over-year growth in total service revenue and adjusted EBITDA, delivers strong free cash flow growth and upgraded guidance for capital expenditures and free cash flowTotal service revenue up 10% to $4.9 billion; adjusted EBITDA up 5% to $2.4 billion Free cash flow growth of $0.2 billion, up 32% Capital intensity improves 500 basis points to 15%Adjusted EBITDA growth continues in both Wireless and Cable with 40,000 mobile phone and Internet subscriber additionsWireless service revenue stable; adjusted EBITDA up 1% Wireless adjusted EBITDA margin up 40 basis points to 65% Added 33,000 total mobile phone net additions, including 28,000 postpaid Mobile phone ARPU1 of $55.60; postpaid mobile phone churn of 1.22% Cable service revenue and adjusted EBITDA up 1%; each up 2% organically excluding data centre...

Continue reading

Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance

– Acquisition Positions Amneal to Capitalize on $300B+ Global Biologics LOE Opportunity – – Transaction Accelerates Growth Profile and Diversification – – Preliminary Q1 Results Reflect Continued Growth and Raising 2026 Full Year Guidance – – Company to Host Investor Conference Call Today at 8:30 a.m. EST – BRIDGEWATER, N.J., April 22, 2026 (GLOBE NEWSWIRE) — Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a diversified, global biopharmaceutical leader focused on expanding access to affordable and innovative medicines, today announced that it has entered into a definitive agreement to acquire 100% of Kashiv BioSciences, LLC (“Kashiv”) in a transaction with consideration that includes $375 million of cash and $375 million of equity payable at closing, plus up to $350 million in potential payments based on...

Continue reading

Invitation to Q1 2026 Results Webcast/Conference Call

Heimstaden Bostad will publish its 2026 First Quarter Report on Wednesday, 29 April 2026 at 08.00 CET. We invite analysts and institutional investors to join a webcast and conference call at 10.00 CET the same day. The Management Team will present the Q1 2026 results and give a business update, followed by a Q&A session. Questions may be asked both verbally and in writing. To participate, please pre-register using one of the links below. Access details will be provided upon registration. Link to register for webcast via laptop (written questions): Webcast registration. Link to register for telephone call (verbal questions): Conference call registration. Following the event, a recording and transcript of the call will be available on our website. For questions or bilateral meeting requests, please contact Investor Relations: ir@heimstaden.com ContactFrederik...

Continue reading

Correction: Corbion announces quarterly sales of € 293.7m and Adjusted EBITDA of € 37.8m; maintains full-year outlook

Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes its results for Q1 2026 ending 31 March. Key results Q1 2026:• Organic sales growth: -4.1%%       ◦ Volume/mix: -2.6%       ◦ Price: -1.5%  • Sales: € 293.7 million  • Adjusted EBITDA: € 37.8 million  • Operating profit: € 14.7 million  Outlook FY 2026:FY 2026 outlook affirmed€ million Q1 2026 Q1 2025   Total growth Organic growthSales 293.7 329.7   -10.9% -4.1%Adjusted EBITDA 37.8 54.4   -30.5% -19.7%Adjusted EBITDA margin (%) 12.9% 16.5%      Operating profit 14.7 34.0   -56.8% -50.0%Commenting on today’s results, Olivier Rigaud, CEO, stated: “In line with earlier guidance, Corbion experienced negative growth in both sales and earnings versus Q1 2025....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.